Alembic Pharma Q2 net surges 81% to ₹335 crore
NDTV Profit

“U.S. business was driven by strong volume growth and new launches. In U.S. Branded, we are encouraged by the traction building across our existing portfolio,” said
Summary from The Hindu
Read the full story on The HinduTimeline
- NDTV Profit first reported it
- The Hindu reported it
- Latest update









